Skip to main content

Test Price

1,800 AED

✅ Home Collection Available

DHA-LICENSED GENOMICS FACILITY

Chromosomal Microarray 60K (Products of Conception) in UAE | 1,800 AED | 2026 DHA Guidelines

تحليل المصفوفات الصبغية الدقيقة 60K (نواتج الحمل) في الإمارات | 1,800 درهم إماراتي | معتمد من هيئة الصحة بدبي

ISO 9001:2015 Certified DHA Facility License: 9834453 TAT: 15–20 Days

Starting Price

1,800

AED

Inclusive of POC Tissue Analysis

الملخص التنفيذي: تحليل المصفوفات الصبغية الدقيقة 60 ألف مسبار لنواتج الحمل هو فحص جيني متطور ومعتمد من هيئة الصحة بدبي، يُستخدم لتحديد الاختلالات الصبغية الدقيقة في أنسجة الحمل بعد فقدان الحمل أو الإجهاض المتكرر. بدقة تشخيصية تبلغ 99.9% عبر مختبرات حاصلة على شهادة الآيزو 9001:2015، نوفر خدمة جمع العينات المنزلية المبرّدة وفق أعلى المعايير السريرية، مع استشارة طبية هاتفية بعد صدور النتائج لتفسيرها إكلينيكياً.


Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited Agilent 60K Microarray Processing
Premium Logistics: Hospital-Grade Home Collection via ISO-Certified Cold-Chain Transport & VIP Mobile Phlebotomy for Maternal Blood
Clinical Guidance: Telephonic Post-Test Clinical Consultation with DHA-Licensed Genetic Counselors for Result Interpretation
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 — Pre-Approval Within 2 Hours

Overview: Chromosomal Microarray 60K (POC) — Precision Genomic Analysis for Pregnancy Loss

Chromosomal Microarray 60K (Products of Conception) is a high-resolution genomic test that detects submicroscopic chromosomal deletions, duplications, and copy number variants (CNVs) in fetal tissue following miscarriage or stillbirth. This test identifies genetic causes of pregnancy loss with resolution down to 100–200 kilobases — far exceeding conventional karyotyping — enabling clinicians to provide accurate recurrence risk counseling and guide future reproductive planning.

يُعد هذا الفحص أداة تشخيصية أساسية لتقييم أسباب فقدان الحمل وراثياً، ويُوصى به بعد الإجهاض المتكرر أو ولادة جنين ميت لتوجيه الاستشارة الوراثية والتخطيط للحمل المستقبلي.

Feature Our Test: CMA 60K POC Conventional Karyotyping FISH Panel (Limited Probes)
Resolution ~100–200 kb (Genome-Wide) 5–10 Mb (Microscope-Visible Only) Targeted Loci Only (3–5 Regions)
Detection Scope CNVs, AOH, Mosaicism, Triploidy Aneuploidy, Large Rearrangements Pre-Selected Aneuploidies Only
Sample Requirement POC Tissue (Sterile Saline/RPMI) + Optional Maternal EDTA Blood Viable Cultured Cells Required Fresh or Fixed Tissue
Turnaround Time 15–20 Days 21–28 Days (Culture-Dependent) 7–10 Days (Limited Scope)
Failure Rate <2% (No Culture Required) 20–40% (Culture Failure Common) 5–15%

Methodology: Agilent SurePrint G3 Human CGH Microarray 60K | Platform validated per ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | LOINC: 62356-1 — loinc.org/62356-1

Physician Insight & Safety Protocol — Dr. Prabhakar Reddy, DHA 61713011

“Chromosomal Microarray on Products of Conception provides families with answers during one of the most difficult clinical moments — pregnancy loss. I emphasize that while this test identifies pathogenic genomic imbalances with high sensitivity, every result must be correlated with maternal history, parental karyotypes when indicated, and comprehensive genetic counseling. No single laboratory finding replaces the clinical judgment of your treating physician.”

— Dr. Prabhakar Reddy, DHA-Licensed Specialist (License No. 61713011), Clinical Genomics & Reproductive Medicine

Medication Warning

Do not discontinue any prescribed medication, hormonal therapy, or anticoagulant regimen without consulting your attending physician. Chromosomal Microarray POC testing does not assess maternal health status, and abrupt medication changes may pose serious clinical risk. For patients on progesterone supplementation, low-molecular-weight heparin, or antihypertensive therapy following pregnancy loss, coordinate all medication adjustments exclusively through your DHA-licensed obstetrician.

Exclusion Criteria & Emergency Red Flags

Exclusion Criteria for POC Sample Collection:

  • Tissue fixed in formalin or any aldehyde-based preservative — only sterile saline or RPMI medium accepted
  • POC specimen collected >72 hours prior without continuous refrigeration (2–8°C)
  • Heavily necrotic or macerated tissue with no identifiable chorionic villi on gross examination
  • Maternal blood collected in heparin tube (green-top) — use EDTA (lavender-top) only
  • Active maternal coagulopathy or severe anemia (Hb <7 g/dL) relative contraindication for maternal phlebotomy

Emergency Red Flags — Seek Immediate Medical Attention:

  • Heavy vaginal bleeding soaking >2 pads/hour for 2 consecutive hours
  • Fever >38.5°C (101.3°F) with chills or foul-smelling vaginal discharge
  • Severe pelvic or abdominal pain unrelieved by prescribed analgesia
  • Syncope, dizziness, or tachycardia suggesting hemodynamic instability
  • Signs of sepsis: confusion, rapid breathing, mottled skin, or decreased urine output

These symptoms may indicate retained products of conception, endometritis, or hemorrhage — all require emergency department evaluation regardless of microarray testing status. Call 998 for UAE ambulance services immediately if symptoms are severe.

Patient FAQ & Clinical Guidance

1. What does Chromosomal Microarray 60K POC detect that standard karyotyping misses?

Chromosomal Microarray 60K detects submicroscopic deletions and duplications as small as 100 kilobases across all 24 chromosomes, identifying pathogenic copy number variants responsible for pregnancy loss that conventional karyotyping — limited to 5–10 megabase resolution — cannot visualize. Additionally, CMA detects areas of homozygosity (AOH) suggestive of uniparental disomy, mosaicism above approximately 10–15%, and triploidy when combined with SNP probe analysis. In clinical cohorts, CMA identifies a clinically significant genetic cause in 8–13% of miscarriage specimens with normal karyotypes, making it the first-tier diagnostic test recommended by ACOG, RCOG, and DHA for Products of Conception analysis in recurrent pregnancy loss.

يكتشف تحليل المصفوفات الصبغية الدقيقة 60K اختلالات صبغية دقيقة لا يمكن رؤيتها بالتنميط النووي التقليدي، مما يفسر أسباب فقدان الحمل المتكرر بدقة أكبر.

2. How should the Products of Conception sample be collected and transported for optimal results?

Products of Conception tissue must be collected in a sterile container with normal saline or RPMI transport medium — never formalin or any fixative — and transported to our ISO-certified laboratory at 2–8°C within 24 hours of collection for optimal DNA integrity. For home collection, our DHA-licensed mobile phlebotomy team arrives with validated cold-chain transport kits within 60 minutes of dispatch. If maternal blood is required for confirmation studies, an EDTA (lavender-top) tube is drawn concurrently. Avoid heparin-based anticoagulants as they inhibit downstream enzymatic reactions. Specimens are accessioned immediately upon receipt, and DNA extraction begins within 4 hours to minimize degradation. Incomplete or improperly collected specimens will be rejected with immediate notification via SMS and phone call to the ordering physician.

يجب جمع نواتج الحمل في وعاء معقم بمحلول ملحي معقم ونقلها مبردة إلى المختبر خلال 24 ساعة للحصول على نتائج دقيقة.

3. Is a doctor's prescription required, and how does insurance coverage work in the UAE?

Yes, a valid prescription from a DHA-licensed Gynecologist, Obstetrician, or Clinical Geneticist is required for Chromosomal Microarray 60K POC testing, and our dedicated insurance verification team processes direct billing approvals via WhatsApp at +971 54 548 8731 within two hours. Prescription requirements may be waived under specific clinical protocols for post-surgical pathology specimens, established recurrent pregnancy loss cases under MOHAP-approved fertility programs, and pre-travel genetic counseling packages — all subject to our Clinical Advisory Board review. We accept all major UAE medical insurance networks including Daman, Thiqa, Neuron, MetLife, AXA, and Bupa. Self-pay patients receive a detailed itemized invoice suitable for insurance reimbursement claims. For minors (patients under 18), testing is governed by UAE Federal Decree-Law No. 41 of 2024, Article 87, and the CDS Law 2026 on Consent for Diagnostic Services, requiring documented parental or legal guardian consent.

يلزم وصفة طبية من طبيب مرخص من هيئة الصحة بدبي لإجراء الفحص، مع إمكانية التحقق من تغطية التأمين الصحي عبر الواتساب.

Pre- Requirements & Logistics

  • Prescription: Required from DHA-licensed Gynecologist, Obstetrician, or Clinical Geneticist (waiver protocols available for surgery-associated POC and approved recurrent pregnancy loss cases)
  • Sample Collection Kit: Provided at no cost — includes sterile container with RPMI medium, EDTA vacutainer for maternal blood, cold-chain transport pack, and chain-of-custody documentation
  • Drug & Supplement Avoidance Prior to Maternal Blood Draw: Discontinue biotin (vitamin B7) supplementation >72 hours before maternal phlebotomy; avoid heparin-based products; continue all prescribed medications unless directed otherwise by your physician
  • Home Collection Hours: 8:00 AM – 11:00 PM daily, including weekends and public holidays
  • Collection-to-Lab Transit: ISO-certified cold-chain (2–8°C) with real-time temperature logging; specimen viability guaranteed for 24 hours post-collection
  • Facility License: DHA 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)

+971 54 548 8731

WhatsApp for Same-Day Booking

Insurance Pre-Approval Available

Regulatory Compliance: This service is provided in full compliance with UAE Federal Decree-Law No. 41 of 2024 (Article 87 — Patient Consent & Diagnostic Service Governance), UAE CDS Law 2026 (Consent for Diagnostic Services — Minors), UAE Personal Data Protection Law (PDPL — Genetic Data Privacy & Confidentiality), and DHA/MOHAP Clinical Laboratory Standards. All genetic data is stored on encrypted, UAE-sovereign servers with access restricted to authorized clinical personnel. Patient results are released exclusively to the ordering physician and the patient through secure, authenticated channels.

2026 ICD-10-CM Codes: O02.1 (Missed Abortion — Early Fetal Death) | N96 (Recurrent Pregnancy Loss) | Z13.79 (Encounter for Screening for Genetic and Chromosomal Anomalies). LOINC: 62356-1 — Chromosome Microarray [Interpretation] in Blood or Tissue by Molecular Genetics Method. Methodology: Agilent SurePrint G3 Human CGH Microarray 60K with SNP backbone — copy number variant (CNV) detection, absence of heterozygosity (AOH) analysis, and mosaicism calling per ACMG 2026 guidelines.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians